Ros Matthew
Officer at Epizyme, Inc.
- Sold, on record
- $3.7M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Feb 4, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Epizyme, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Epizyme, Inc.UnusualFeb 5 2018
Sold 72,264 shares at $16.63 ($1.2M)
Ros Matthew, Chief Operating Officer
Sold 96.5% of holdings ($1.2M position)2,603 shares leftFirst sale on recordFiling
- 2 Form 4 sale Epizyme, Inc.Plan not statedJun 13 +493 days
Sold 1,185 shares at $12.10 ($14k)
Ros Matthew, Officer
Sold 2.9% of holdings ($487k position)39,032 shares leftFiling
- 3 Form 4 sale Epizyme, Inc.Plan not statedJan 24 +225 days
Sold 1,847 shares at $24.64 ($46k)
Ros Matthew, Officer
Sold 4.2% of holdings ($1.1M position)42,185 shares leftFiling
- 4 Form 4 sale Epizyme, Inc.Plan not statedMar 25 +61 days
Sold 1,243 shares at $15.28 ($19k)
Ros Matthew, Officer
Sold 2.3% of holdings ($810k position)51,798 shares leftFiling
- 5 Form 4 sale Epizyme, Inc.UnusualJun 18 +85 days
Sold 112,003 shares at $21.24 ($2.4M)
Ros Matthew, Officer
Sold 68.4% of holdings ($3.5M position)51,798 shares left90.1x usual sizeFiling
- 6 Form 4 sale Epizyme, Inc.Plan not statedJun 26 +8 days
Sold 2,728 shares at $16.15 ($44k)
Ros Matthew, Officer
Sold 4.5% of holdings ($973k position)57,507 shares left1.8x usual sizeFiling
- 7 Form 4 sale Epizyme, Inc.Plan not statedJan 25 +213 days
Sold 2,872 shares at $11.41 ($33k)
Ros Matthew, Officer
Sold 4.9% of holdings ($671k position)55,957 shares left1.6x usual sizeFiling
- 8 Form 4 sale Epizyme, Inc.Plan not statedFeb 4 +10 days
Sold 894 shares at $11.21 ($10k)
Ros Matthew, Officer
Sold 1.1% of holdings ($943k position)83,188 shares left0.4x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2021 | Epizyme, Inc. | Officer | Form 4 sale | 894 | $10k | 1.1% | Plan not stated | SEC |
| Jan 25, 2021 | Epizyme, Inc. | Officer | Form 4 sale | 2,872 | $33k | 4.9% | Plan not stated | SEC |
| Jun 26, 2020 | Epizyme, Inc. | Officer | Form 4 sale | 2,728 | $44k | 4.5% | Plan not stated | SEC |
| Jun 18, 2020 | Epizyme, Inc. | Officer | Form 4 sale | 112,003 | $2.4M | 68.4% | Unusual | SEC |
| Mar 25, 2020 | Epizyme, Inc. | Officer | Form 4 sale | 1,243 | $19k | 2.3% | Plan not stated | SEC |
| Jan 24, 2020 | Epizyme, Inc. | Officer | Form 4 sale | 1,847 | $46k | 4.2% | Plan not stated | SEC |
| Jun 13, 2019 | Epizyme, Inc. | Officer | Form 4 sale | 1,185 | $14k | 2.9% | Plan not stated | SEC |
| Feb 5, 2018 | Epizyme, Inc. | Chief Operating Officer | Form 4 sale | 72,264 | $1.2M | 96.5% | Unusual | SEC |